M Foz
Impact in
-
- Growth Hormone and Insulin-like Growth Factors
- Thyroid Cancer Diagnosis and Treatment
- Thyroid Disorders and Treatments
- Pituitary Gland Disorders and Treatments
- Hepatology top 10%
- Hepatitis C virus research
Papers in ⓘ
-
- Growth Hormone and Insulin-like Growth Factors 4
- Thyroid Disorders and Treatments 3
- Hormonal Regulation and Hypertension 3
-
- Liver Disease Diagnosis and Treatment 2
- Co-authors
- Anna Sanmartı́ (8 shared papers)I. Salinas (7 shared papers)Anna Lucas (5 shared papers)Laura Audı́ (3 shared papers)Roberto Muga (5 shared papers)Jordi L. Reverter (2 shared papers)Lurdes Matas (1 shared paper)José Domínguez (1 shared paper)
In The Last Decade
M Foz
28 papers receiving 598 citations
Peers
Comparison fields: 5 of 78
- Endocrinology, Diabetes and Metabolism 235
- Hepatology 103
- Endocrinology 65
- Virology 33
- Epidemiology 236
Countries citing papers authored by M Foz
This map shows the geographic impact of M Foz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Foz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Foz more than expected).
Fields of papers citing papers by M Foz
This network shows the impact of papers produced by M Foz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Foz. The network helps show where M Foz may publish in the future.
Co-authors
The 25 scholars most cited alongside M Foz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 116 | |
| 2 | 1990 | 109 | |
| 3 | 1992 | 81 | |
| 4 | 2000 | 49 | |
| 5 | 1990 | 48 | |
| 6 | 1997 | 37 | |
| 7 | 1991 | 34 | |
| 8 | 1996 | 32 | |
| 9 | 1993 | 27 | |
| 10 | 2009 | 14 | |
| 11 | 1992 | 11 | |
| 12 | 1983 | 11 | |
| 13 | 2001 | 8 | |
| 14 | 1980 | 7 | |
| 15 | 1990 | 7 | |
| 16 | [HIV infection declines among intravenous drug addicts in Barcelona: 1987-1993]. | 1994 | 5 |
| 17 | [Dyslipemia and HIV-1 infection in intravenous drug addicts]. | 1993 | 5 |
| 18 | 2001 | 3 | |
| 19 | 1990 | 3 | |
| 20 | [Morbid obesity: surgical treatment (I). Criteria of obesity, inclusion and preoperative evaluation]. | 1991 | 3 |
About M Foz
M Foz is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology, Infectious Diseases, Molecular Biology and Virology, having authored 28 papers that have together received 625 indexed citations. Recurring topics across this work include Growth Hormone and Insulin-like Growth Factors (4 papers), Thyroid Disorders and Treatments (3 papers), HIV Research and Treatment (3 papers), Hormonal Regulation and Hypertension (3 papers), Liver Disease Diagnosis and Treatment (2 papers), Immune Cell Function and Interaction (2 papers), Forensic Toxicology and Drug Analysis (2 papers) and HIV-related health complications and treatments (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (235 citations), Hepatology (103 citations), Endocrinology (65 citations), Virology (33 citations) and Epidemiology (236 citations). M Foz has collaborated with scholars based in Spain and Russia. Frequent co-authors include Anna Sanmartı́, I. Salinas, Anna Lucas, Laura Audı́, Roberto Muga, Jordi L. Reverter, Lurdes Matas, José Domínguez, J. M. Manterola and Tor J. Their work appears in journals such as Clinical Endocrinology, Endocrine Research, Clinical Infectious Diseases, European Journal of Clinical Nutrition and Thrombosis and Haemostasis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.